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1. Introduction 
The term of brachytherapy, also known as “internal radiotherapy, sealed source 
radiotherapy, curietherapy or endocurietherapy” is from Greek work brachy means short 
distance and therapy (treatment) and also known as internal radiotherapy or sealed source 
radiotherapy. Brachytherapy is a special form of radiotherapy where a radioactive source is 
carefully placed on or inside the area to be treated. Brachytherapy sources are usually 
encapsulated; they can be used within the body cavities close to the tumor, placed in a 
lumen of organs, implanted in to the tumor or placed over the tissue to be treated. The main 
purpose in radiation therapy is controlling disease and reducing side effects. For a good 
clinical result one must assure the dose concentrate in the tumor mass and surrounding 
volume which is at risk of the tumor micro-extensions, while minimizing radiation received 
by the normal tissue. This can be verified by experimental measurement which is the base of 
Brachytherapy dosimetry.  Due to the high dose gradient near the source and low signal to 
noise ratio at great distances, experimental dosimetry in Brachytherapy is very complicated 
or even in small distances is impossible. Also the dose variation with angle in 4Ǒ geometry 
of the source must be considered, since routine experimental measurement does not 
represent this. One of the widely used techniques for solving this problem is Monte Carlo 
simulation of radiation transport. The calculation of dose distributions at small distances 
and also validation of experimental measurement can be done by one of the powerful codes 
such as MCNP, BEAM, EGSnrc, PENELOPE, GEANT4, and ETRAN/ITS. One of the 
important parameters in the calculation process is validation of the Monte Carlo calculations 
with measurement results.  
This chapter starts with an introduction lecture about brachytherapy history and a short 
review of the different models for sealed Brachytherapy sources. A brief discuss of 
brachytherapy dosimetry with computer and measurement is provided. In 1995 the 
American Association of Physicists in Medicine (AAPM) Task Group No. 43 published a 
protocol including new formalism for brachytherapy dose calculation and updated in 2004 
as TG-43U1. The concept of AAPM recommendation and TG 43 formalism are introduced. 
Application of Monte Carlo in simulation, guideline for Monte Carlo dosimetry, calculation 
methodology, requirement for simulation and validation of calculation are then outlined. A 
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short overview of other application of Monte Carlo in brachytherapy such as eye plaque and 
applicator design, evaluation of treatment planning system calculation is described. Finally 
an example of Monte Carlo calculations for dosimetric parameters of 103Pd brachytherapy 
seed in three geometric models based on different location of beads inside the capsule is 
provided. 
2. History 
The use of radioactive sources for treatment of cancerous tumours started shortly after the 
discovery of radium (226Ra) in 1898 by Madame Curie. This was followed in 1901 by Pierre 
Curie’s self exposure experiment. Brachytherapy developed largely through the use of 
sealed radium and radon sources, but, quantities and forms of radioactivity useful for 
brachytherapy were not available until 1940s, when civilian applications of nuclear reactors 
were encouraged. In 1950s Radium-226 tubes with 1 mm Pt filtration remained the 
dominant intracavitary source through the late 1960s. Due to the revolutionary of all 
radiotherapy developments like beam therapy and need of experience to position the 
brachytherapy sources with sufficient accuracy and radiation exposure hazards for 
personnel, the role of brachytherapy was not secure in that era. However, over the past 
three decades, there has been renewed interest in the use of brachytherapy for a number of 
reasons. The discovery of man-made radioisotopes and remote afterloading techniques has 
reduced radiation exposure hazards. Newer imaging techniques (CT scan, magnetic 
resonance imaging, ultrasound) and computerized treatment planning has helped to achieve 
good clinical outcomes. The advantages of brachytherapy to surgery are treatment 
simplicity, minimum damage to the surrounding normal tissues and the reduction of side 
effects for patient after treatment. The advantages of brachytherapy to tele-therapy are its 
ability in radiation localization on tumor tissue, minimizing radiation to the surrounding 
normal tissues and rapid dose reduction in normal tissues surrounding the tumor (Ataeinia 
et al., 2009). 
226Ra sealed in platinum tubes or needles, was the first radionuclide used in brachytherapy 
treatments. Radium has the advantage of a very long half-life (1620 years), but it also has the 
disadvantage of producing the alpha-emitting gaseous daughter product radon. 222Rn, the 
daughter product of 226Ra has a half-life of 3.83 days, in a gas form was extracted and sealed 
within a gold seed, was later used for permanent implants.  (Baltas et al., 2007). By the early 
1950s, both 226Ra and 222Rn have been replaced by newly developed isotopes and 
brachytherapy had become a well-established and mature modality (Williamson, 2006). In 
1950s when produced of other nuclides became available, radium and radon replaced with 
other new produced radionuclides and they are no longer used.  Most common 
brachytherapy sources emit photons; however, in a few specialized situations such as 
Craniopharyngiomas which are pediatric tumors, accounting for about 6% of all intracranial 
tumors in children, ǃ emitting sources are used (Sadeghi et al., 2009a). Brachytherapy 
photon emitter sources are available in various forms (needles, tubes, seeds, wires, pellets) 
but are generally sealed to provide shielding against the undesired ǂ and ǃ radiation 
emitted from the sources and also to prevent leakage.  These sources are used in various 
types of brachytherapy implant. Sources can be place in to the body cavities near to the 
tumours (intracavitary), trains of sources are loaded within the lumen of organs 
(interaluminal), sources are implanted within the tumours (interstitial), or a single source is 
placed into small or large arteries (intravascular). The dose is then delivered continuously, 
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either over a short period of time (temporary implants) or over the lifetime of the source to a 
complete decay (permanent implants) (Mayles et al., 2007). 
3. Sources used in brachytherapy 
Depending on the dose rate of the sources at the dose specification point, brachytherapy 
treatment classified in three categories: high dose rate sources (HDR) >12 Gy/h, high energy 
photon emitters s like 137Cs, 60Co, 192Ir, 198Au are used, medium dose rate (MDR) 2-12 Gy/h, 
is not common use; and low dose rate sources (LDR), less than 2 Gy/h with low energy 
photon emitters such as 125I and 103Pd (Bethesda, 1985). A brachytherapy source is 
characterized by the rate at which its strength decays (half-life), by how much radioactivity 
can be obtained for a given mass of the radioactive source (specific activity), by the energies 
and types of the radiation particles that are emitted from the source (energy spectrum). 
These physical brachytherapy source characteristics will guide the clinical utilization. 
Currently the sources used in brachytherapy categorized in high and low energy sources:  
i.     Cesium-137:  137Cs, a fission by-product, is a popular radium substitute because of its 30-
year half-life. It emits ǃ-rays and 0.662 MeV Ǆ-photons. 137Cs intracavitary tubes are 
mostly used for intracavitary treatment of gynaecological malignancies. The radioactive 
material is distributed in insoluble glass micro-spheres. The active source material is 
then sealed in stainless steel encapsulation cylinders. 
ii. Cobalt-60: 60Co is produced from thermal neutrons captured by 59Co. it emits 0.318 MeV 
ǃ-rays, 1.17 MeV and 1.33 MeV Ǆ-photons and has a half-life of 5.27 years. Cobalt 
sources are encapsulated with 0.1 to 0.2 mm platinum to filter the ǃ-particles. 
iii. Iridium-192: 192Ir with a half-life of 73.8 days is the most widely used source for 
temporary interstitial implants. It emits Ǆ-photons with energies ranging from 9 to 884.5 
keV.  192Ir is used in the form of a wire containing an iridium–platinum radioactive core 
in a sheath of platinum; and also available in seed format (0.5-mm diameter by 3 mm 
long) with an active core cylinder contained in stainless steel or platinum 
encapsulation. The seeds are encapsulated in a 0.8-mm-diameter nylon ribbon and can 
used in wire format.  
iv. Gold-198: 198Au is produced by reactor irradiation of pure gold. Insoluble 198Au emits ǃ-
rays and 412 keV Ǆ-photons; and decays with half-life of 2.7 days. Sources are available 
for use in intracavitary treatment of the oesophagus in seeds, grains and wires format. 
Gold-198 seeds are 2.5 mm long and 0.8 mm in outer diameter, and have 0.15-mm-thick 
platinum encapsulation. 
And low energy sources: 
v. Iodine-125: 125I emits Ǆ-rays and X-rays with energies below 0.0355 MeV and have a 
half-life of 59.7 days. 125I sources are packed in a cylindrical encapsulation of titanium 
shell of 4.5 mm in length and 0.8 mm in diameter, and used mostly for permanent 
implant treatments of cancers of the prostate, lung, sarcomas, as well as the temporary 
implant treatment of ocular melanoma when loaded in an eye plaque. 
vi. Palladium-103: 103Pd is an alternative to 125I for permanent implants. 103Pd has lower 
energy emissions, 20 keV, which allow for a rapid decrease in dose with distance, and 
also, the short half- life, 17 days, results in higher dose rates and also greater biological 
effect than 125I. This radionuclide is available in seed format, encapsulated in titanium 
tube. 
www.intechopen.com
Applications of Monte Carlo Methods in Biology, Medicine and Other Fields of Science 158 
Some physical characteristics of these common brachytherapy sources are summrized in 
Table 1. (Ling et al., 1995; Nath et al., 2005; Antipas et al., 2001; Wuu & Zaider, 1998).  
 
Isotope 
Average 
photon energy 
(MeV) 
Half-life 
Half value 
layer in 
lead (mm) 
Form of use 
137Cs 0.662 30 a 6.5 Tube – needle – pellet- seed 
60Co 1.250 5.26 a 11 Tube– needle- pellet 
192Ir 0.397 73.8 a 3 Wire - seed 
198Au 0.412 2.7 d 2.5 Seed 
125I 0.028 60 d 0.02 Seed 
103Pd 0.021 17 d 0.01 Seed 
Table 1. Some Characteristics of Isotopes Used In Brachytherapy 
4. Dose distributions around the sources 
Dosimetry, as used in brachytherapy, means the methodology of calculating the dose rate 
value at an interest point from a source in a given medium. It is important that the physicist 
know the theoretical basic of dose calculation, manually or using a computer algorithm, 
around the source in adjacent healthy and critical organs. In modern brachytherapy all 
available sources have a cylindrical geometry, and are fabricated in core and encapsulation 
form that can assume a cylindrical symmetry of the dose distribution to their longitudinal 
axis. The base of brachytherapy dosimetry is experimental measurements and any other 
theoretical calculations must be validated against measured values. But due to the high dose 
gradient near the source and low signal to noise ratio at great distances, experimental 
dosimetry in Brachytherapy is very complicated and in small distances has had a higher 
degree of uncertainty. Calculation the dose in any points and angles is available by 
theoretical methods. To improve calculation accuracy it is desirable to make use of Monte 
Carlo method, which is a computational tool that samples from known probability 
distributions to determine the average behaviour of a system, it is used in medical physics, 
particularly in brachytherapy to improve our understanding of all processes associated with 
radiation emission and transport by using random numbers. So Monte Carlo becomes a 
powerful tool in medical physics applications (Rogers, 2006; Baltas et al., 2007; Calatayud et 
al., 2009). 
In the Monte Carlo calculations the real source geometry and material is considered; to 
facilitate the calculations the American Association of Physicists in Medicine (AAPM) Task 
Group No.43, in 1995 published a protocol (TG-43) introducing a new formalism for dose 
calculation that the different component of the dose calculation be divided into geometry, 
attenuation, scattering and anisotropy. This approach is used in modern treatment planning 
systems and suitable for commissioning. After that in 2004 the AAPM Low-energy 
Interstitial Brachytherapy Dosimetry subcommittee (LIBD) published an update version of 
the TG-43 protocol for calculation of dose rate distributions around photon-emitting 
brachytherapy sources (TG-43U1) (Nath et al., 1995; Rivard et al., 2004).  
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5. The TG-43 formalism 
The proposed formula for two-dimensional dose rate is: 
 ܦሶ ሺݎ, ߠሻ ൌ ܵ௄߉ ீሺ௥,ఏሻீሺ௥బ,ఏబሻ ݃ሺݎሻܨሺݎ, ߠሻ   (1) 
Where ܦሶ ሺݎ, ߠሻ is the dose rate in water at the distance r in cm from a line source and ߠ 
denotes the polar angle specifying the point of interest as shown in Figure 1, ܵ௄ is the air -
kerma strength has unit of ܷ ൌ ܿܩݕ ܿ݉ଶ ݄ିଵ, ߉ is the dose rate constant expressed in ܿܩݕ ݄ଶିଵ ܷିଵ; ீሺ௥,ఏሻீሺ௥బ,ఏబሻ is the geometry factor; ݎ଴, ߠ଴ are the reference position,  ݎ଴ ൌ ͳ ܿ݉ and ߠ଴ ൌ 9Ͳ଴ , ݃ሺݎሻ is the radial dose function; and ܨሺݎ, ߠሻ is the anisotropy function. 
 
 
Fig. 1. Coordinate system used for brachytherapy dosimetry calculations. 
5.1 Brachytherapy source strength 
Source-strength designation has gone through several changes over the years. The earliest 
quantity (mass of radium) was commonly referred to by the unit, milligram radium and 
still is used in some cases. For sealed sources, especially those of low energy, the 
encapsulation reduces the air kerma and dose rates below those which would be produced 
by the bare source. Thus the strength is generally given as apparent activity, which is less 
than the encapsulated activity. Apparent activity is the activity of a hypothetical point 
source of the same radionuclide which would produce the same air kerma rate, at the same 
large distance, as that measured on the transverse axis of a sealed source. The design of the 
source capsule also influences the dose distribution around the source. It is quite possible 
for two sources of the same radionuclide and same apparent activity to have different dose 
distributions. (Nath et al., 1997). 
5.2 Air-kerma strength, ࡿࡷ 
Air-kerma strength is the product of air-kerma rate in free space at the measured distance 
from the source centre along the perpendicular bisector, r, multiplied by the square of this 
distance, r2: 
 ܵ௄ ൌ  ܭሶఋሺݎሻݎଶ   (2)                          
Distance r must be chosen large enough, relative to the linear dimension of the source, to 
find independent air kerma strength of distance.  ܭሶఋሺݎሻ is the air kerma rate in vacuo and for the photons of energy greater than a certain cut-
off value of δ which is typically 5 keV for low-energy photon emitting sources . This value is 
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dependent on the assumption that photons with energies up to this cut-off value are not 
tissue penetrating. The qualification ‘‘in vacuo’’ means that the measurements should be 
corrected for photon attenuation and scattering in air and any other medium interposed 
between the source and detector. 
5.3 Dose-rate constant, Λ 
The dose rate constant, Λ, is defined as the dose rate in water at the reference point, ܦሺሶ ݎ଴, ߠ଴ሻ , namely at a distance of r0=1 cm on the transverse axis (θ=900), per unit air kerma 
strength, SK, as seen in Equation (3): 
 Λ ൌ Dሺሶ ୰బ,θబሻSK    (3)                          
 
The dose rate constant depends on both the radionuclide and source model, and is 
influenced by both the source design (radioactive distribution and encapsulation) and also 
the methodology used to determine ܵ௄ .  
5.4 Geometry function, ࡳࢄሺ࢘, ࣂሻ 
The geometry function, GXሺr, θሻ, takes into account the effect of the distribution of 
radioactive material inside the capsule on the dose distribution and is a function of both r 
and θ. physically it provides an effective inverse square-law and neglects scattering and 
attenuation of emitting photons around the source (Karaiskos et al., 2000). The subscript “X” 
is to indicate a point-source, “P” or line-source, “L”, geometry function. The values of the 
geometry function can then be calculated as follow: ܩ௉ሺݎ, ߠሻ ൌ ݎିଶ      For the point-source   
ܩ௅ሺݎ, ߠሻ ൌ ቐ ఉ௅௥ ୱ୧୬ ఏሺݎଶ െ ௅మସ ሻିଵቑ ݂݅ ߠ ് Ͳ௢݂݅ ߠ ൌ Ͳ௢      For the line-source  (4)ߚ ൌ tanିଵሺ ݎ sin ߠݎ cos ߠ െ ܮ/ʹሻ െ ሺ ݎ sin ߠݎ cos ߠ ൅ ܮ/ʹሻ  
 
Where β is the angle in radians, subtended by P(r,θ) and two ends of active length of the 
source. In the case where radioactive material is distributed over a cylindrical volume,   the 
active length, L, will be the length of the cylinder (Fig.1). For brachytherapy sources 
containing multiple radioactive pellets, L is given by: 
 ܮ௘௙௙ ൌ ߂ܵ ൈ ܰ  (5) 
 
Where N is the number of discrete pellets contained in the source, and ߂ܵ is the center to 
center distance of the pellets. The active length should be less than the length of source 
capsule. In the case where it is greater, the effective length of the seed is considered the 
distance between proximal and distal aspects of the activity distribution.  
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5.5 Radial dose function, ࢍࢄሺ࢘ሻ 
The radial dose function describes the effect of tissue attenuation on photons emitted from a 
brachytherapy source and accounts for the dose fall-off along the source transverse axis due 
to the photon scattering and attenuation. Equation (6) is defined the ݃௑ሺݎሻ as: 
 ݃௑ሺݎሻ ൌ ܦሶ ሺݎ, ߠ଴ሻܦሶ ሺݎ଴, ߠ଴ሻ ܩ௑ሺݎ଴, ߠ଴ሻܩ௑ሺݎ, ߠ଴ሻ , ܺ ൌ ܲ ݋ݎ ܮ ሺܲ݋݅݊ݐ ݋ݎ ݈݅݊݁ ݏ݋ݑݎܿ݁ሻ (6) 
5.6 2D anisotropy function, ࡲሺ࢘, ࣂሻ 
The 2D anisotropy function describes the variation of dose in the longitudinal plane of the 
seed. Variations are due to the distribution of radioactivity within the seed, self-absorption 
and oblique filtration of the radiation in the encapsulating material. Fሺr, θሻ Is obtained by the 
following formula: ܨሺݎ, ߠሻ ൌ ܦሶ ሺݎ, ߠሻܦሶ ሺݎ, ߠ଴ሻ ܩ௅ሺݎ, ߠ଴ሻܩ௅ሺݎ, ߠሻ  (7) 
6. The use of Monte Carlo to obtain the dosimetric parameter 
The most important role of Monte Carlo in brachytherapy is to obtain the dosimetric 
parameters of the sources with high spatial resolution. As mentioned above, “dosimetry” 
refers to estimation of absorbed dose by means of experimental or fundamental theoretical 
techniques about single brachytherapy sources. Due to the high dose gradient near the 
brachytherapy sources at short distances in water or water-equivalent phantoms, near-field 
dosimetry of brachytherapy sources is very complicated. To avoid dosimeter averaging 
effects, very high resolution (les than 0.5 mm) dosimeters are required (Chiu-Tsao et al., 
2007; Williamson 1991); also low energy-response of some detectors; and lake of 
reproducibility, increase the uncertainty in experimental dosimetry. 
Monte Carlo simulation is the theoretical method for calculation of dosimetric parameters. 
Monte Carlo simulation easily can obtain dosimetric parameters at small distances and all 
angles without any limitation and complication. For low energy photon emitters such as 125I 
and 103Pd, photoelectric absorption contributes a larger proportion of the dose to tissue than 
for higher energies. Therefore, small variations in tissue atomic number result in significant 
effects on dose. These effects can also be calculated precisely by Monte Carlo simulation by 
replacing the different phantom materials in different geometries (Dale et al., 1985; Prasad 
1985; Huang 1990). 
According to TG-43U1 recommendation, the main guideline items that should be 
considered in MC simulation for accurate calculations are as follow: 
1.    The information of source dimension, composition of encapsulation and internal 
components and their geometry must be specified clearly; typically these data obtained 
by manufacturer’s report and Monte Carlo allows complete flexible description of the 
real geometry of the sources. 
2.    Simulation should be performed in a 30 cm water phantom for low energy photon-
emitters like 125I and 103Pd, and 40 cm water phantom for high energy photon-emitters 
such as 137Cs and 192Ir, to consider all the scattering effects of the surrounding medium. 
3.    To extract the absorbed dose distribution from the particle transport simulation, one has 
to define a so-called tally or scoring function. The size and position of scoring voxels 
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(detectors) should define in a way to decrease the uncertainty; usually Monte Carlo 
uses voxels at radial distances up to 10 cm, for low energy sources and to 15 cm for high 
energy sources, away from the source at different polar angles. The voxel sizes are an 
important issue in simulation. To minimize the systematic error, the voxel sizes should 
be small as low as possible.   
4.    Enough histories should be calculated to ensure that the statistical uncertainties are in 
confidence range. 
5.    The statistical uncertainty should be ≤2% (for r < 5 cm) and ≤1% in ܵ௄  with k=1. 
6.    Due to the lake of old cross-section libraries for low energy photons, modern and new 
cross-section libraries should be used in Monte Carlo simulation.  
7.    Mechanical movement of the internal component of the seeds should be considered in 
the simulation. Because the location of the sources can vary with seed orientations and 
can affect on dosimetric parameters. 
To calculate the dosimetric parameters, two simulations are needed: one with the source 
model in the medium which is usually water phantom, to obtain the dose at interest points; 
second simulation by modelling in vacuum to obtain the air kerma strength and geometry 
function. For low energy photon emitters such as 125I and 103Pd, the source is modelled in a 
centre of a 30 cm spherical water phantom, large enough to consider effects of the 
surrounding medium. For HDR sources like 137Cs and192Ir, the photon energies are higher 
than those emitted by 125I and 103Pd, therefore a 40 cm diameter spherical phantom is 
considered for modelling (Rivard, 2007; Perez-Calatayud et al., 2004; Melhus and Rivard, 
2006). Generally for low energy photon emitters, ܵ௄ is calculated in several air-filled 
detectors at distances ranging from 5 to 150 cm in the transverse plane in free air geometry, 
which is found to be independent of distance. Due to the low energy of the photons from the 
low energy sources, it is assumed in the Monte Carlo calculations all electrons generated by 
the photon collisions are absorbed locally and the electronic equilibrium exists, so dose is 
equal to kerma at all points of interest [Hosseini et al., 2009 & Sadeghi et al., 2008b]. 
It should be noted that for high energy sources, electronic equilibrium, and consequently, 
water kerma dose approximation, may be safely assumed only at distances greater than 1 
mm from the sources (Wang & Li 2000, Baltas 2001). 
Geometry function just provides the inverse square low correction depending only on the 
shape of the active core and not on the encapsulation or radionuclide. Thus the medium 
inside and around the source has been considered as vacuum in order to disregarded the 
absorption and scattering in the seed and the surrounding media. The geometry function 
value is given by Equation (4).  For calculating geometry function, the mass densities of all 
materials within the entire computational geometry should be set equal to zero so there 
were no interaction and particles streamed through the seed phantom geometry and it is 
common to approximate the active source material distribution within a brachytherapy 
source by an idealized geometry such as a line. (Levitt et al. 2006, Rivard 2001). 
 To obtain radial dose function values, Monte Carlo method is the best choice. Due to the 
complication of experimental measurement at small distances, dose rates are estimated 
down to the smallest distances and experimental values are only consider for validation of 
the Monte Carlo simulation results. By applying the Equation (6) radial dose function, which 
is the radial dependence of the dose rate value at the reference polar angle, θ=90º, is 
obtained and equal to unity at distance 1 cm. Dose rates can be estimated by linear 
interpolation from data tabulated at discrete points. The tabulated values are fit to 
polynomial which is proposed in TG-43U1. 
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 ݃௑ሺݎሻ ൌ ܽ଴ ൅ ܽଵݎ ൅ ܽଶݎʹ ൅ ܽଷݎ͵ ൅ ܽସݎͶ ൅ ܽହݎͷ   (8) 
Parameters ܽ଴ to ܽହ should be calculated by fifth order polynomial fit to the tabulated ݃௑ሺݎሻ 
data within ±2%. Commonly radial distance range for low energy sources is from 0.5 to 7.0 
cm and for high energy sources is up to 15.0 cm. Depending on the source encapsulation 
design, in some cases calculation at distance as low as 0.1 cm could be also needed. 
The values of the anisotropy function, defined by Equation (7), can be derived from Monte 
Carlo calculated at different radial distances from r= 0.25 to 7.0 cm for low energy sources 
and up to 15.0 cm for high energy sources, and different polar angles from θ=0º to 90º for 
symmetric sources about the transverse plane and from θ=0º to 180º for source design that 
are asymmetric about the transverse plane. According to Equation (7), the anisotropy 
function value at any radial distance on transfer plan, is always 1.0. Its value off the transfer 
plan decreases as:  r increases, encapsulation thickness increases, θ approaches 0º or 180º 
and energy of photon decreases (Bethesda et al., 1985).  
7. Validation of Monte Carlo modelling 
As the Monte Carlo method has its own uncertainties, the preferred general approach is to 
use other determination method, and compare the results. According to TG-43U1 
recommendation and other research publications, it has been accepted as a standard method 
that validation of Monte Carlo calculations via independent studies is required. To verify 
the Monte Carlo calculations, the experimental data sets should be compared with 
calculated data. For the experimental dosimetry in brachytherapy it is necessary to 
introduce a dosimeter in the radiation field of a source which should provide a measurable 
reading and present an adequate sensitivity with small sensitive volume to avoid dose 
volume averaging. The dosimetric system that provides optimum compromise between 
these prerequisites is TL dosimetry TLDs are currently considered as the dosimeter of choice 
for experimental dosimetry in the entire energy range of brachytherapy sources and TLD 
dosimetry is an accepted approach to validate the Monte Carlo simulation. Because the 
value of dosimetric parameters strongly depends on source material, seed model, 
encapsulation thickness and geometry, the experimental measurement should be done for 
the same seed which is modeled in Monte Carlo simulation. The steep dose gradient around 
low energy radio-nuclides such as 125I and 103Pd causes significantly dosimetric uncertainty. 
So the validation should be done for the larger distances, for example 1-5 cm then all other 
data especially for small distances, can get from Monte Carlo results. For other sources with 
higher energy like 137Cs and 192Ir, the dependence of dosimetric parameters of source 
geometry and material is low and measured value can obtain from similar source design.  If 
the Monte Carlo and experimental datasets are compatibles within the acceptable 
uncertainties, a set of consensus value of dosimetric parameters would be established. The 
consensus data were defined as the ideal candidate dataset having the highest resolution, 
covering the largest distance range, and having the highest degree of smoothness. The 
consensus dose rate constant value should be obtained by the averaged experimental and 
Monte Carlo Λ values:  
 CONΛ= [ EXPΛ+ MCΛ]/2.  (9) 
Or it should be selected as being representative of the collection of values available in the 
literature.   
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The consensus values for anisotropy function and radial dose function for most source 
models are mostly selected from Monte Carlo results that spanned the required range of 
radial distances and angles and had sufficiently fine spacing to make the interpolation 
between points accurate. Also Monte Carlo study considers the beta particles and electrons 
emitted by the source. 
8. Other application of Monte Carlo 
The Monte Carlo dose calculations are mostly used to obtain the dosimetric parameters 
around the brachytherapy sources to use in treatment planning systems. Calculated data 
provide the specific dose distributions based upon the actual locations of the sources in and 
around the patient; and also as a benchmarking tool for treatment planning systems 
(Williamson et al., 1999; Anagnostopoulos et al. 2003). The main goal of clinical treatment 
planning is to find the best way to maximize the tumor dose and minimize the dose to the 
healthy tissue. Most current commercial treatment planning systems implemented the TG-
43 formalism and the recommended dosimetry parameters in their systems to determine the 
dose distributions. Monte Carlo calculations can obtain the approximations in the 
calculations done by the treatment planning system. For low-energy sources, a major 
problem is characterizing tissue heterogeneities, requires estimation of the photoelectric 
cross section as well as tissue density these can have significant errors near inhomogeneities 
in the patient. Monte Carlo dose calculations can account for tissue-composition 
heterogeneities (Chibani and Williamson, 2005; Devic et al. 2000). Monte Carlo dose 
calculations, when carefully validated against measurements, provide the highest level of 
accuracy for dose calculation in treatment planning, in situations where measurements are 
difficult or even impossible. Monte Carlo also can use for study and design of applicators. 
Intracavitary brachytherapy is mostly used for cancers of the cervix, uterine and vagina.  
Several rigid applicators have been used for intracavitary brachytherapy but it requires 
careful design of the applicators and precise placement of the sources with respect to the 
tumor volume and surrounding organs. The most clinical complication of intracavity 
brachytherapy in this case results from the high dose delivered to the critical surrounding 
organs such as bladder and rectum. Because the common types of source for treatment of 
gynecology are high energy sources, 137Cs and 192Ir.  Monte Carlo simulation can play an 
important role to keep the dose to these critical organs as low as possible by obtain the dose 
rate in interest points. 
Another use of Monte Carlo in brachytherapy is its application in design of eye plaque. 
Radioactive eye plaque therapy is incorporating the use of radioactive seeds in a widely 
used technique for the treatment of ocular tumors. Monte Carlo simulation is performed to 
fully model the brachytherapy seeds loaded in the eye plaque to obtain the dose distribution 
in critical ocular structure and central axis of plaque. Brachytherapy seeds are placed in slots 
within a polymer carrier, Monte Carlo is possible to obtain the attenuation effect of the 
plaque backing, most often made of gold or stainless steel, and polymer carrier (Acrylic or 
Silastic) on dose distribution. Physical characteristics of photons emitted by different seed 
models (position, energy, location, and direction) are strongly dependent on seed 
construction, especially since brachytherapy sources are often constructed of high atomic 
number materials.  In some cases, due to the presence of seed carrier inside the plaque the 
emitted photons from sources attenuate, thus more ܵ௄ per seed is needed to deliver the 
prescription dose to the tumor volume, that can be obtained by Monte Carlo simulation. For 
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example Granero et al., 2004 calculated the dose rate around the eye plaque loaded with 125I 
sources in Acrylic insert and they found Acrylic insert has no attenuation effect on dose rate 
and the presence of acrylic insert can be negligible in the calculations. In other Mont Carlo 
simulations Chiu-Tsao et al., 1993, obtained 10% dose reduction at 1cm for Silastic insert; 
Thomson et al., 2008 reported 17% dose reduction for 103Pd seed at distance of 1 cm in eye 
plaque due to presence of Silastic insert; and also calculated results by (Melhus & Rivard, 
2008) demonstrated approximately 22.6%±0.5%, 13.0%±0.3%, and 10.8%±0.3% more ܵ௄ in 
each 103Pd, 125I, and 131Cs seed contained in a eye plaque, respectively was required to 
deliver the same dose to the apex of tumor. 
According to the Monte Carlo calculated data, size, shape and location of the eye tumor, 
standard eye plaque should design. Iodine-125 is currently the most commonly used source 
for radioactive eye plaque therapy. Few centers use palladium-103, and available reports 
indicate that because of its low energy emissions 20 keV which allow for a rapid decrease in 
dose with distance; and also, the short half-life, 17 days, result in higher dose rates and 
favorable dose distribution (Finger et al., 1999; Hall et al. 1991; Finger et al., 1991; Sadeghi & 
Hosseini, 2010). Generally for the Monte Carlo simulation, the eye plaque is centered in a 15 
cm radius water phantom to provide adequate photon backscatter and large enough to 
consider all the scattering effects of the surrounding medium. The Monte Carlo simulations 
provide the dose in a voxel per history. The dose rate is calculated by dividing this number 
by the air kerma strength per history for the relevant seed type and multiplying by the 
number of seeds and the air kerma strength per seed:  
 ሶ݀ ሺݔ, ݕ, ݖሻ ൌ ሶ݀ሺݔ, ݕ, ݖሻௌ௉ ൤ ܵ௄ ቀௌ஺಼ ቁିଵ ܭ௦௢௨௥௖௘ ൨ . ݊   (10) 
Where ሶ݀ ሺݔ, ݕ, ݖሻ is the dose rate at the position x,y,z to deliver the prescription dose; ሶ݀ ሺݔ, ݕ, ݖሻௌ௉  is the dose rate per starting particle at position x,y,z; ܵ௄௦௢௨௥௖௘  is the ܵ௄ሺܷሻ per 
source needed to deliver ሶ݀ ሺݔ, ݕ, ݖሻ; ௌ஺಼  is the ratio of the ܵ௄ሺܷሻ and activity A(mCi) for a given 
source; K is the photons emitted per unit activity and n is the number of sources. Finally the 
total dose is calculated by integration ሶ݀ ሺݔ, ݕ, ݖሻ over the prescribed treatment time. 
According to American Brachytherapy Society recommendation for uveal melanoma the 
prescription treatment time is 3 to 7 consecutive days to deliver a total prescription dose. 
The prescription dose depends on the prescription point, method of dose prescription and 
dosimetry calculation assumption but following the Collaborative Ocular Melanoma Study 
(COMS) group dosimetry calculation assumption, is 85 Gray to the tumor apex (Nag et al., 
2003; Baltimore 1995; Melia et al., 2001; Granero et al., 2010). In fact Monte Carlo Calculated 
dose rate for the eye plaque at interested point in the eye region has helped design of eye 
plaque as a valuable brachytherapy dosimetry tool. 
9. Example of Monte Carlo calculations for dosimetric parameters of 
103
Pd 
brachytherapy seed 
This example presents Monte Carlo (MC) simulation results for the dosimetry parameters of 
the IR-103Pd seed (Saidi et al., 2010).  
Dose distributions in this example were simulated with the MCNP5 Monte Carlo (MC) 
radiation transport code published by Los Alamos National Laboratory (mcnp-
green.lanl.gov/index.html., 2008) and the MCPLIB04 photon cross-section library is based 
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on the ENDF/B-VI data (BNL.NCS-17541, 8th ed., 2000). In the calculations, the titanium 
characteristic X-ray production were suppressed with ǅ=5 keV (ǅ is the energy cutoff) (Nath 
et al., 1995). The spherical water phantom was modeled with a 30 cm diameter with an 
atomic ratio of 2:1 for H:O and ǒ=0.998 g/cm3. The seed source placed in the center of the 
phantom for the calculation of all dosimetric parameters at radial distances of r= 0.25, 0.5, 
0.75, 1, 2, 3, 4, 5 and 7 cm, away from the source and at polar angles relative to the seed 
longitudinal axis from 0° to 180° with 10° increment. To validate the Monte Carlo 
simulation, results were compared by experimental values (Raisali et al., 2008). The 
simulations were performed up to 1.1 × 109 histories. With this number of histories, 
statistical uncertainty for the source along the longitudinal axis at r ≤ 5 cm is lower than 
1.3%, at 7 cm is 4.5% and at other angles it is between 0.04% and 0.1%. In air, with 1.5 × 108 
histories, statistical uncertainty is 0.1%. 
Figure 2(a), shows a schematic diagram of the IR-103Pd seed. The seed contains five resin 
beads, which are packed inside a titanium cylinder of 4.8 mm length, 0.7 and 0.8 mm 
internal and external diameter respectively, and with an effective length of 3 mm. 103Pd 
radioactive material is absorbed uniformly in the resin bead volume. As the beads are free to 
move within the titanium capsule, their location can vary with seed orientations. Saidi et al. 
(2010), simulated three geometric models of the seed, ideal, vertical and diagonal, as shown 
in Figure 2(a), (b) and (c) respectively.  
 
 
(a) 
 
(b) 
 
(c) 
Fig. 2. Schematic diagram of the IR-103Pd seed in Monte Carlo calculation for various seed 
orientations: (a) Ideal orientation, (b) vertical orientation, and (c) diagonal orientation (103Pd 
absorbed in resin). 
The dose rate constant for the 103Pd seed was calculated by using the Equation (3). Due to 
the low energy of the photons from 103Pd, it was assumed in the Monte Carlo calculations all 
electrons generated by the photon collisions are absorbed locally, so dose is equal to kerma 
at all points of interest (Sadeghi et al., 2008b). The air-kerma rate of the IR-103Pd seed in this 
example was estimated by calculating the dose in 1 mm-thick air-filled rings in a vacuum. 
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The rings were bounded by 86° and 94° conics and defined with a radial increment of 5 cm 
to 150 cm along the transverse axis of the source and also the MCNP F6 tally, was used for 
calculate the dose distribution around the seed in each of the three orientations consider in 
this work. 
 
Source type Method Medium Λ (cGy h-1 U-1) Reference 
IR-103Pd 
Monte Carlo 
(vertical) 
Liquid water 0.695±0.021 Saidi et al. (2010) 
IR-103Pd Monte Carlo (ideal) Liquid water 0.716±0.021 Saidi et al. (2010) 
IR-103Pd Monte Carlo (ideal) Liquid water 0.706±0.001 Raisali et al. (2008) 
New 103Pd 
Monte Carlo 
(vertical) 
Liquid water 0.673±0.001 Rivard et al. (2004b) 
New 103Pd 
Monte Carlo 
(vertical) 
Liquid water 0.675±0.020 Saidi et al. (2010) 
MED3633 
TLD dosimetry Solid water 0.688±0.05 Wallac & Fan (1999) 
Monte Carlo Liquid water 0.677±0.02 Li et al. (2000) 
Theragenics 200
TLD dosimetry Solid water 0.650±0.08 Nath et al. (2000) 
Monte Carlo Liquid water 0.686±0.03 William (2000) 
Table 2. Monte Carlo calculated dose rate constant, Λ, of the IR-103Pd seed and new 103Pd 
source and comparison with the measured and calculated values of model MED3633 and 
Theragenics200. 
 
Fig. 3. Comparison of the Monte Carlo calculation radial dose function of IR-103pd (Saidi et 
al., 2010) seed with the MED3633 and Theragenics model 200 sources (Rivard et al., 2004a). 
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Fig. 4. Comparison between measured (Raisali et al., 2008) and calculated results (Saidi et 
al., 2010) for IR-103Pd seed anisotropy functions at selected radial distances of (a) 2 cm, (b) 3 
cm, (c) 5 cm. 
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(a) r2G(r,θ)/G(r0,θ0)  for ideal seed orientation. 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 
0.25 1.529 1.487 1.382 1.260 1.149 1.059 0.992 0.947 0.921 0.912 
0.50 1.100 1.098 1.086 1.067 1.046 1.025 1.006 0.992 0.983 0.980 
0.75 1.046 1.045 1.041 1.033 1.024 1.015 1.007 1.000 0.996 0.994 
1.00 1.025 1.028 1.026 1.021 1.017 1.012 1.007 1.003 1.000 1.000 
1.50 1.014 1.016 1.015 1.014 1.011 1.009 1.007 1.005 1.004 1.003 
2.00 1.009 1.011 1.011 1.010 1.009 1.008 1.007 1.005 1.005 1.005 
3.00 1.001 1.008 1.008 1.008 1.008 1.008 1.007 1.006 1.006 1.006 
4.00 1.000 1.008 1.008 1.008 1.007 1.007 1.007 1.006 1.006 1.006 
5.00 1.000 1.007 1.007 1.007 1.007 1.007 1.007 1.007 1.006 1.007 
7.00 0.998 1.007 1.007 1.007 1.007 1.007 1.007 1.007 1.006 1.006 
(b)  r2G(r,θ)/G(r0,θ0)  for ideal orientation calculated by Raisali et al. (2008) 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 
0.25 1.514 1.484 1.383 1.259 1.148 1.058 0.991 0.947 0.920 0.911 
0.50 1.102 1.098 1.086 1.066 1.046 1.025 1.006 0.993 0.983 0.981 
0.75 1.068 1.044 1.040 1.033 1.024 1.015 1.007 1.000 0.996 0.994 
1.00 1.031 1.028 1.025 1.022 1.017 1.012 1.008 1.003 1.001 1.000 
1.50 1.006 1.015 1.014 1.013 1.011 1.009 1.007 1.005 1.004 1.002 
2.00 1.002 1.011 1.009 1.010 1.009 1.008 1.007 1.005 1.006 1.005 
3.00 0.996 1.008 1.008 1.009 1.007 1.007 1.007 1.007 1.006 1.005 
4.00 1.002 1.008 1.008 1.008 1.007 1.006 1.007 1.007 1.006 1.005 
5.00 0.997 1.007 1.007 1.007 1.006 1.006 1.006 1.007 1.006 1.007 
7.00 0.995 1.008 1.007 1.006 1.006 1.007 1.007 1.007 1.006 1.006 
(c)  r2G(r,θ)/G(r0,θ0)  for vertical seed orientation. 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 100° 110° 120° 130° 140° 150° 160° 170° 180° 
0.25 1.510 1.436 1.275 1.121 0.944 1.529 1.287 1.225 1.086 0.911 0.919 0.930 0.990 1.057 1.102 1.258 1.380 1.452 1.519 
0.50 1.915 1.908 1.791 1.650 1.482 1.379 1.230 1.129 1.056 0.980 0.981 0.987 1.006 1.022 1.039 1.067 1.084 1.101 1.088 
0.75 1.476 1.460 1.449 1.377 1.317 1.236 1.167 1.106 1.046 0.994 0.994 1.005 1.005 1.015 1.022 1.034 1.039 1.043 1.044 
1.00 1.287 1.324 1.297 1.261 1.226 1.177 1.136 1.075 1.035 1.000 0.998 1.002 1.007 1.010 1.018 1.020 1.025 1.034 1.001 
1.50 1.164 1.195 1.186 1.169 1.145 1.141 1.091 1.060 1.029 1.003 1.002 1.005 1.007 1.008 1.014 1.012 1.014 1.021 0.987 
2.00 1.114 1.147 1.136 1.121 1.107 1.086 1.058 1.045 1.023 1.005 1.003 1.006 1.007 1.008 1.012 1.009 1.009 1.017 0.986 
3.00 1.064 1.098 1.082 1.080 1.077 1.114 1.048 1.035 1.019 1.006 1.004 1.006 1.007 1.007 1.011 1.007 1.009 1.014 0.981 
4.00 1.039 1.076 1.065 1.061 1.058 1.048 1.065 1.027 1.018 1.006 1.004 1.007 1.007 1.007 1.011 1.006 1.007 1.013 0.979 
5.00 1.026 1.063 1.051 1.047 1.052 1.034 1.029 1.026 1.009 1.006 1.004 1.007 1.007 1.008 1.011 1.006 1.006 1.013 0.978 
7.00 1.036 1.046 1.045 1.042 1.034 1.027 1.024 1.027 1.010 1.010 1.004 1.011 1.005 1.005 1.011 1.011 1.011 1.011 1.002 
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(d)  r2G(r,θ)/G(r0,θ0)  for diagonal seed orientation. 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 100° 110° 120° 130° 140° 150° 160° 170° 180° 
0.25 1.588 1.449 1.324 1.209 1.121 1.027 0.985 0.001 0.909 0.911 0.920 0.929 0.987 1.042 1.097 1.248 1.277 1.435 1.507 
0.50 1.020 1.051 1.054 1.046 1.021 1.005 0.994 0.990 0.990 0.980 0.983 0.986 1.004 1.020 1.036 1.062 1.076 1.095 1.073 
0.75 0.992 1.001 1.010 1.010 1.000 0.998 0.997 0.994 0.994 1.384 1.388 1.391 1.413 1.432 1.451 1.481 1.498 1.522 1.492 
1.00 1.026 0.993 0.993 0.996 0.993 0.996 0.998 0.995 1.000 1.000 1.001 1.002 1.006 1.011 1.016 1.018 1.023 1.031 1.012 
1.50 1.012 0.982 0.982 0.984 0.987 0.993 0.998 0.999 1.001 1.004 1.004 1.004 1.006 1.009 1.013 1.011 1.015 1.020 1.002 
2.00 0.996 0.977 0.979 0.982 0.984 0.990 0.996 1.002 1.001 1.005 1.005 1.006 1.006 1.009 1.012 1.008 1.012 1.017 0.992 
3.00 0.989 0.975 0.977 0.986 0.985 0.992 0.999 1.003 1.002 1.006 1.006 1.007 1.006 1.009 1.011 1.006 1.012 1.014 0.987 
4.00 0.998 0.975 0.978 0.989 0.989 0.995 1.002 1.003 1.003 1.007 1.007 1.007 1.007 1.009 1.011 1.006 1.012 1.014 0.983 
5.00 1.005 0.985 0.979 0.990 0.992 1.001 1.007 1.007 1.004 1.007 1.007 1.007 1.007 1.009 1.011 1.005 1.007 1.013 0.982 
7.00 1.003 0.985 0.978 0.990 0.992 1.001 1.007 1.007 1.004 1.225 1.225 1.225 1.225 1.231 1.231 1.219 1.225 1.237 1.175 
Table 3. Monte Carlo calculated r2G(r,θ)/G(r0,θ0)  for the IR-103Pd seed (Saidi et al., 2010) in (a) 
ideal orientation , (b) ideal orientation calculated by Raisali et al. (2008), (c) vertical 
orientation, (d) diagonal orientation. 
Also in this example authors benchmarked their MCNP simulation with the new 103Pd 
source (Rivard et al., 2004b) to demonstrate the accuracy of their simulation. For the three 
seed orientations, the values of Λ in three orientations, ranged from 0.716 to 0.753 cGyU-1h-
1, with the geometry uncertainty of 1.5% for this seed. According to TG43U1, a standard 
uncertainty of 3% for all Monte Carlo studies seems reasonable. Authors claimed that the 
difference between the calculated values of dose rate constant by the Raisali et al., (2008) 
value, derives from the use of different methods to calculate the air-kerma strength, SK. 
Raisali et al. calculated SK only in one air-filled detector placed at a distance of one meter in 
the transverse plane of the seed. Also use of two different versions of MCNP code, MCNP4C 
& MCNP5 with two different cross section libraries and two different simulation geometries 
cause such a difference in the obtained values. Table 2 shows the calculated dose rate 
constant for the IR-103Pd seed (Saidi et al., 2010), new 103Pd source (Rivard et al., 2004b) and 
the calculated and measured values of Λ, for NASI model MED3633 and Theragenics model 
200 sources (Rivard et al., 2004b). 
The Monte Carlo calculated values of geometry function in this example for three 
orientations are shown in Table 3(a), (c) and (d). They used the form, r2G(r,θ),  instead of 
G(r,θ), for easier calculations and then  normalized to G(1cm,π/2) for convenience to 
compare with other published data (Rivard, 2001; King et al., 2001). The results were 
compared with Raisali et al., (2008) data.  
The calculated line and point source radial dose function for the ideal orientation of the 
IR-103Pd seed in Perspex and water in this example and those determined from calculated 
and measurement by (Raisali et al., 2008) are presented in Table 4. Figure 3 shows a 
comparison of the radial dose function of IR-103Pd seed with MED3633 and Theragenics 
model 200 sources.  
As TG43-U1 recommendation, gL(r) for ideal orientation in water was fit to a fifth order 
polynomial function (Equation 8): 
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Where a0 = 1.534, a1 = -5.933×10-1, a2 = 2.731×10-2, a3 = 2.362×10-2, a4 = -4.778×10-3 and 
a5 = 2.783×10-4 define R² = 9.998×10-1. 
 
 
 
r (cm) 
gL(r) (Perspex)  gL(r) (Water)  gP(r) (Water) 
MCNP5 TLD MCNP4C  MCNP5 MCNP4C  MCNP5 
Saidi et al. 
(2010) 
Raisali et 
al. (2008) 
Raisali et 
al. (2008) 
 
Saidi et al. 
(2010) 
Raisali et 
al. (2008) 
 
Saidi et al. 
(2010) 
0.25 1.532 - 1.168  1.390 1.339  1.092 
0.5 1.242 1.15 1.134  1.242 1.239  1.229 
0.75 1.077 - 1.070  1.112 1.119  1.114 
1 1.000 1.00 1.000  1.000 1.000  1.000 
1.5 0.711 0.82 0.849  0.763 0.783  0.773 
2 0.668 0.78 0.706  0.573 0.602  0.573 
3 0.393 0.51 0.473  0.331 0.348  0.334 
4 0.169 0.31 0.306  0.165 0.198  0.166 
5 0.085 0.20 0.195  0.089 0.111  0.090 
7 0.025 - -  0.027 0.035  0.027 
Table 4. Monte Carlo calculations for radial dose function, gL(r) and gP(r) for line and point 
source geometry for IR-103Pd seed with an effective length of 0.3 mm, in comparison with 
TLD measurements of Raisali et al., (2008) in Perspex and also calculated in water. 
 
 
 
 
Fig. 5. Comparison of the Monte Carlo calculation anisotropy function of IR-103Pd seed 
(Saidi et al., 2010) with the MED3633 and Theragenics model 200 sources (Rivard et al., 
2004a) at the distance of 5 cm. 
www.intechopen.com
Applications of Monte Carlo Methods in Biology, Medicine and Other Fields of Science 172 
The anisotropy function, F(r,θ), of the IR-103Pd seed was calculated in Perspex phantom at 
radial distances of  r = 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5and 7 cm relative to the seed center and 
polar angle, θ ranging from 0° to 90° for ideal orientation and 0° to 180° for vertical and 
diagonal orientations in 10° increment with respect to the seed long axis. Saidi et al.’s (2010) 
results are shown in Table 5 and in compared with the measured data by Raisali et al., 
(2010), for ideal orientation. The data are shown graphically at distances of 2, 3 and 5 cm in 
Figure 4. Figure 5 shows a comparison of the anisotropy function at r = 5 cm of the IR-103Pd 
with MED3633 and Theragenics model 200 sources. 
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(a) 2D anisotropy function, F(r,θ) in ideal seed orientation 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 
Фan 
(r) 
0.25 0.025 0.076 0.656 0.833 0.906 0.950 0.975 0.991 0.998 1.000 1.023 
0.50 0.106 0.162 0.505 0.738 0.864 0.926 0.962 0.985 0.996 1.000 0.910 
0.75 0.150 0.206 0.505 0.720 0.851 0.921 0.959 0.984 0.996 1.000 0.892 
1.00 0.158 0.221 0.482 0.674 0.794 0.862 0.901 0.924 0.936 1.000 0.838 
1.50 0.206 0.276 0.529 0.717 0.841 0.915 0.956 0.982 0.995 1.000 0.861 
2.00 0.243 0.303 0.541 0.720 0.840 0.914 0.956 0.982 0.995 1.000 0.884 
3.00 0.272 0.338 0.557 0.726 0.839 0.914 0.955 0.980 0.994 1.000 0.885 
4.00 0.298 0.362 0.571 0.731 0.842 0.912 0.955 0.981 0.995 1.000 0.887 
5.00 0.314 0.382 0.581 0.735 0.843 0.915 0.956 0.984 0.995 1.000 0.889 
7.00 0.377 0.417 0.610 0.747 0.848 0.916 0.951 0.979 1.000 1.000 0.894 
(b) 2D anisotropy function, F(r,θ) in vertical seed orientation 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 100° 110° 120° 130° 140° 150° 160° 170° 180° 
0.250 0.039 0.487 0.671 0.862 0.966 0.928 0.993 0.989 0.996 1.000 0.807 0.802 0.783 0.778 0.739 0.658 0.459 0.326 0.024 
0.500 0.157 0.380 0.528 0.771 0.900 0.953 0.967 0.988 0.979 1.000 0.801 0.814 0.787 0.759 0.731 0.605 0.394 0.283 0.112 
0.750 0.217 0.425 0.303 0.748 0.865 0.887 0.917 0.979 0.999 1.000 0.828 0.814 0.756 0.723 0.709 0.598 0.231 0.321 0.180 
1.000 0.173 0.354 0.455 0.608 0.732 0.790 0.777 0.801 0.810 1.000 0.809 0.803 0.774 0.782 0.716 0.587 0.422 0.325 0.184 
1.500 0.271 0.468 0.639 0.757 0.898 0.931 0.962 0.987 0.993 1.000 0.993 0.990 0.957 0.935 0.883 0.730 0.597 0.437 0.274 
2.000 0.308 0.492 0.630 0.762 0.893 0.983 0.962 0.989 0.994 1.000 0.957 0.990 0.957 1.033 0.883 0.735 0.593 0.462 0.307 
3.000 0.359 0.523 0.603 0.769 0.898 0.933 0.961 0.989 0.998 1.000 0.997 0.989 0.956 0.927 0.882 0.743 0.568 0.493 0.352 
4.000 0.384 0.549 0.704 0.784 0.902 0.931 0.963 0.995 0.999 1.000 0.998 0.990 0.958 0.917 0.883 0.752 0.666 0.514 0.370 
5.000 0.422 0.567 0.674 0.782 0.913 0.907 0.961 0.996 0.998 1.000 0.997 0.987 0.955 1.000 0.883 0.756 0.638 0.531 0.398 
7.000 0.398 0.408 0.597 0.739 0.873 0.919 0.949 0.996 0.999 1.000 0.998 0.979 0.999 0.900 0.848 0.993 0.999 0.997 0.427 
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(c) 2D anisotropy function, F(r,θ) in diagonal seed orientation 
r (cm) 0° 10° 20° 30° 40° 50° 60° 70° 80° 90° 100° 110° 120° 130° 140° 150° 160° 170° 180° 
0.250 0.026 0.075 0.630 0.801 0.887 0.924 0.970 0.985 0.988 1.000 1.000 1.000 1.000 0.997 0.995 0.995 1.033 0.974 0.974 
0.500 0.098 0.170 0.492 0.725 0.846 0.909 0.953 0.985 1.005 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.986 0.974 0.974 
0.750 0.139 0.220 0.490 0.706 0.833 0.906 0.950 0.982 1.002 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.986 0.974 0.974 
1.000 0.223 0.342 0.659 0.927 1.095 1.198 1.260 1.294 1.321 1.000 1.409 1.409 1.409 1.405 1.401 1.401 1.388 1.372 1.372 
1.500 0.206 0.292 0.513 0.699 0.822 0.902 0.949 0.978 0.995 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.985 0.974 0.974 
2.000 0.240 0.312 0.525 0.701 0.821 0.900 0.948 0.981 0.993 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.985 0.974 0.974 
3.000 0.270 0.353 0.541 0.709 0.822 0.905 0.950 0.979 0.992 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.982 0.974 0.974 
4.000 0.296 0.383 0.555 0.716 0.829 0.906 0.955 0.981 0.994 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.982 0.974 0.974 
5.000 0.317 0.410 0.566 0.725 0.832 0.911 0.958 0.986 0.995 1.000 1.000 1.000 1.000 0.997 0.995 0.995 0.986 0.974 0.974 
7.000 0.380 0.448 0.594 0.736 0.837 0.913 0.953 0.981 1.000 1.000 1.000 1.000 1.000 0.995 0.986 0.987 0.885 0.867 0.876 
Table 5. 2D anisotropy functions for the IR-103Pd seed calculated by Monte Carlo method 
(Saidi et al., 2010) for the (a) ideal orientation, (b) vertical orientation, (c) diagonal 
orientation. 
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